Wikipedia -WSS

Wikipedia

author：entertainment 2025-09-30 19:25:18 - browse：5124

WASHINGTON — Plenty of pharmaceutical executives have decried Democrats’ new drug pricing law as detrimental to the industry. But few are willing to say they may be willing to delay treatments for cancer patients if it means making more money.

Genentech CEO Alexander Hardy, in an interview with STAT, explained that in the world that existed prior to the Inflation Reduction Act’s passage last year, drugmakers were incentivized to get drugs on the market as fast as possible, regardless of which disease they would be approved to treat.

Now, he’s arguing that the law’s new Medicare negotiation program could encourage Genentech to slow-walk research on how a drug could treat diseases with smaller populations in favor of making sure diseases with larger patient populations are the first to market. That would mean the company would sell more medicines in the window before Medicare is allowed to negotiate prices, because the clock for when discounts can kick in is based off of when the drug first goes on the market.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： FDA approval of Sarepta Duchenne genetic therapy gives me hope
Next article： Diversity in clinical trials starts with building trust, experts say

entertainment

WSS

Dogs on Prozac: What pet anti

Why rehabilitation engineers need to center patients in their research

Cholera vaccine supply gets boost as demand surges globally

BIO: Crackdown on China pharma industry would threaten U.S. drug supply

Cyberattack on UnitedHealth subsidiary cripples pharmacies, hospitals

Cancer researcher Catriona Jamieson is sending tumors into space

knowledge

Wikipedia

focus

What does generative AI mean for health care? We asked experts

STAT readers on older presidents, polypills, Medicare, and more

Malaria cases in Florida and Texas: Here’s what you need to know

The Readout: Abbvie and Humira, CRISPR in utero, Annovis Bio

Moonlake's readout produced a cash windfall. Risks remain

Cell therapy fails to slow type 1 diabetes, but safety is established

Trump demands the U.S. pay no more for drugs than other countries … again

Bird flu outbreak in cows is latest avian flu curveball

Tori Bowie and the unacceptable rates of Black maternal death

New documents shed light on MD Anderson Cancer Institute feud

hotspot

After traumatic brain injury, life support decisions can use more time

Dario to buy mental health app maker Twill in cash and stock deal

Readout Newsletter: Wegovy, dialysis, Humira, Vir, and more

Readout Newsletter: Alnylam, Celldex, Roche, Zealand Pharma

MassMutual is introducing free genetic testing for members

MassMutual is introducing free genetic testing for members

entertainment

hotspot

entertainment

hotspot